Scientists are closer than ever to slowing, stopping, and even preventing this devastating disease.

Alzheimer’s used to feel like a life sentence—a slow, painful goodbye with no way to fight back. For years, families watched their loved ones fade, powerless to stop it. In the battle against Alzheimer’s, there is real hope for seniors confronting this challenge. FDA-approved therapies now offer simpler at-home dosing and extended maintenance to slow early cognitive decline by clearing brain plaques, while research unveils fresh targets like a key neuronal enzyme that curbs plaques and genetic risks in models, plus a refined lithium compound reversing pathology in animals with human trials on deck.
Non-drug breakthroughs, including targeted brain stimulation that slows decline by 44% and preventive studies testing plaque therapies before symptoms emerge, pave the way for earlier action, complemented by oral options for high-risk gene carriers and gene therapies to protect neurons. Though no cure yet, these strides champion proactive screening and expert guidance to manage the disease effectively.












